BRAF and follicular variant thyroid gland papillary carcinoma: Our findings provide clinical-diagnostic validation for the fundamental molecular dichotomy, wherein classical PTC is strongly associated with BRAF V600E mutations, while FVPTC is predominantly driven by mutations in the RAS gene family (18).